Is Heron Therapeutics, Inc. (HRTX) a Buy, Sell, or Hold?
NASDAQ : HRTX
Heron Therapeutics, Inc. — Earnings Estimates
$0.4969 USD
$0.0 (-0.1%)
- Volume
- 827.51K
- Average Volume
- 3.37M
- Market Capitalization
- $94.05M
- P/E Ratio
- -2.80
- Dividend Yield
- 0.00%
- Price Target
- $6.00
- Year High
- $1.88
- Year Low
- $0.38
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.53
Annual earnings financials
HRTX financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
HRTX Estimated and Actual Revenue by Quarter
HRTX Estimated and Actual EPS by Quarter
HRTX Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2026-12-31 | 1 | -28.22M | -27.34M | -27.78M | -28.74M | -27.85M | -28.29M |
| 2026-09-30 | 1 | -25.29M | -24.5M | -24.9M | -25.76M | -24.96M | -25.36M |
| 2026-06-30 | 1 | -25.44M | -24.64M | -25.04M | -25.91M | -25.1M | -25.5M |
| 2026-03-31 | 2 | -22.16M | -21.41M | -21.79M | -22.58M | -21.81M | -22.2M |
| 2025-12-31 | 2 | -23.69M | -23.63M | -23.66M | -24.13M | -24.07M | -24.1M |
| 2025-09-30 | 3 | -23.48M | -22.84M | -23.16M | -23.92M | -23.26M | -23.59M |
HRTX Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2026-12-31 | 1 | -1.94M | -1.86M | -1.9M | 47.24M | 48.76M | 48M |
| 2026-09-30 | 1 | -1.94M | -1.86M | -1.9M | 42.35M | 43.71M | 43.03M |
| 2026-06-30 | 1 | -967.75K | -928.71K | -948.23K | 42.58M | 43.95M | 43.27M |
| 2026-03-31 | 2 | -5.9M | -2.95M | -4.43M | 37M | 38.3M | 37.66M |
| 2025-12-31 | 2 | -3.87M | -3.71M | -3.79M | 40.83M | 40.94M | 40.89M |
| 2025-09-30 | 3 | -2.9M | -2.79M | -2.84M | 39.47M | 40.58M | 40.03M |
HRTX Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2026-12-31 | 1 | 46.07M | 47.55M | 46.81M | 1 | -0.01020587 | -0.00979413 | -0.01 |
| 2026-09-30 | 1 | 41.29M | 42.62M | 41.95M | 1 | -0.01020587 | -0.00979413 | -0.01 |
| 2026-06-30 | 1 | 41.52M | 42.86M | 42.19M | 1 | -0.00510293 | -0.00489707 | -0.005 |
| 2026-03-31 | 2 | 36.08M | 37.35M | 36.72M | 1 | -0.03111067 | -0.01555533 | -0.023333 |
| 2025-12-31 | 2 | 39.82M | 39.92M | 39.87M | 1 | -0.02041173 | -0.01958827 | -0.02 |
| 2025-09-30 | 3 | 38.48M | 39.57M | 39.03M | 2 | -0.0153088 | -0.0146912 | -0.015 |